Skip to main content
The Egyptian Heart Journal

Table 3 Comparing patients with electrical events on Holter monitoring at baseline and after completion of treatment

From: Assessing the impact of a combination of sofosbuvir and daclatasvir treatment for hepatitis C virus infection on heart rate, rhythm and heart rate variability using 24-hour ECG monitoring

Variable

Baseline

After completion of treatment

p value

Sinus tachycardia episodes, n = 48

35.29 ± 46

29.69 ± 27.15

0.81

Sinus bradycardia episodes, n = 40

7.88 ± 7.56

7.95 ± 8.1

0.795

PACs, n = 8

6.63 ± 7.37

7.5 ± 17.3

0.89

PVCs, n = 27

71.6 ± 147

31.89 ± 69.26

0.124

  1. Continuous variables are expressed as mean and standard deviation. PA Cs premature atrial contractions PVCs premature ventricular contractions
Back to article page